Get in touch today 206.598.4100 or

Schedule an Appointment

Jeannette Hammond, PA-C

Teaching Associate


Jeannette Hammond, PA-C, was part of the University of Washington’s radiation oncology team at Seattle Cancer Care Alliance at South Lake Union and has nearly a decade of experience working in the medical oncology field.

Education and Training

College: BA Chemistry, St. Olaf College, Northfield, MN, 1992

Graduate School: MS Chemistry, University of Colorado, Boulder, CO, 1995

Medical Education: Physician Assistant Certification Program, Northeastern University, Boston, MA, 1999

Published Works

Rodler, E.T., Specht, .JM.,Gadi, V.K., Kurland, B.K. ,Griffin,M.J., Hammond, J. and Gralow, J.R. “Phase 1 Study of PARP inhibitor ABT-888 (Veliparib) in combination with cisplatin and vinorelbine for patients with advanced triple negative breast cancer and/or BRCA associated breast cancer”( 2011) Cancer Research volume 71, Issue 24, Supplement 3. SABC 11-Pl-17-04

Hendrickson, H.S., Hendrickson, E.K., Johnson, J.L., Khan, T.H., Chia I, H.J. ” Kinetics of Bacillus cereus phosphotidylinositol- specific phospholipase C with thiophosphate and fluorescent analogs of phosphotidylinositol” (1992) Biochemistry 31, 12169-12172.

Hendrickson, E.K., Johnson, J.L., & Hendrickson, H.S. ” A thiophosphate substrate for continuous spectrophotometric assay of phosphotidylinositol- specific phospholipase C: hexadecylthiophosphoryl-1- myo-inositol” (1991) Bio/Med. Chem Lett. 1, 615-618.

Hendrickson, E.K.,Johnson, J.L., & Hendrickson, H.S. ” A fluorescent substrate for the assay of phosphotidylinositol- specific phospholipase C: 4-(1- pyreno)butylphosphoryl-1-myo-inositol” (1991) Bio/Med. Chem. Lett. 1,619-622.

Board Certification

Physician Assistant Certified, 1999